Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer at Intellia Therapeutics. Filing since 4 Aug 2021.
CIK 0001777421
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
3 Jan 2025
EVP, Chief Scientific Officer
Sold at will
8,966
$109.21K
10.4%
NTLA
Intellia Therapeutics, Inc.
8 Jan 2024
EVP, Chief Scientific Officer
Sold on a plan
2,275
$65.68K
4.9%
NTLA
Intellia Therapeutics, Inc.
3 Jan 2024
EVP, Chief Scientific Officer
Sold at will
5,532
$162.97K
10.7%
NTLA
Intellia Therapeutics, Inc.
5 Jan 2023
EVP, Chief Scientific Officer
Sold, plan not stated
2,330
$89.66K
11.7%
NTLA
Intellia Therapeutics, Inc.
4 Jan 2023
EVP, Chief Scientific Officer
Sold, plan not stated
2,508
$93.32K
11.2%
NTLA
Intellia Therapeutics, Inc.
1 Jan 2022
EVP, Chief Scientific Officer
Sold, plan not stated
1,148
$128.86K
19.3%
NTLA
Intellia Therapeutics, Inc.
30 Aug 2021
EVP, Chief Scientific Officer
Sold, plan not stated
97,000
$15.02M
97.6%
NTLA
Intellia Therapeutics, Inc.
4 Aug 2021
EVP, Chief Scientific Officer
Sold, plan not stated
26,000
$3.59M
91.6%
8 decisions on file.
